{"task_id": "2b3e4cee7391453f", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 284/905)", "text": "nsplantation. \nWhat is hepatorenal syndrome (HRS)?\n\n--- Page 290 ---\n276\nGastroenterology\nCirrhosis\nCirrhosis (Greek kirrhos = yellow) implies irreversible liver damage. Histologically, there \nis loss of normal hepatic architecture with bridging \ufb01 brosis and nodular regeneration.\nCauses Most often chronic alcohol abuse, HBV, or HCV infection. Others: see BOX \n\u2018Causes of cirrhosis\u2019.\nSigns Leuconychia: white nails with lunulae undemarcated, from hypo-\nalbuminaemia; Terry\u2019s nails\u2014white proximally but distal \u2153 reddened by telangi-\nectasias; clubbing; palmar erythema; hyperdynamic cir culation; Dupuytren\u2019s \ncontracture; spider naevi (\ufb01 g 6.27); xanthelasma; gynaecomastia; atrophic testes; \nloss of body hair; parotid enlargement (alcohol); hepatomegaly, or small liver in \nlate disease; ascites; splenomegaly.\nComplications Hepatic failure: Coagulopathy (failure of hepatic synthesis of \nclotting factors); encephalopathy (p259); hypoalbuminaemia (oedema); sepsis \n(pneumonia; septicaemia); spontaneous bacterial peritonitis (SBP); hypoglycaemia. \nPortal hypertension: Ascites (\ufb01 g 6.28); splenomeg aly; portosystemic shunt includ-\ning oesophageal varices (\u00b1 life-threatening upper GI bleed) and caput medusae \n(enlarged super\ufb01 cial periumbilical veins). HCC: \ue000 risk.\nTests Blood: LFT: \ue009 or \ue000bilirubin, \ue000AST, \ue000ALT, \ue000ALP, \ue000\ue034GT. Later, with loss of synthetic \nfunction, look for \ue001albumin \u00b1 \ue000PT/INR. \ue001WCC & \ue001plate l ets indicate hypersplenism. \nFind the cause: ferritin, iron/total iron-binding capacity (p288); hepatitis serol-\nogy (p278); immunoglobulins (p290); autoantibodies (ANA, AMA, SMA, p553); \ue025-feto\nprotein (p286); caeruloplasmin in patients <40yrs old (p285); \ue0251-antitrypsin (p290). \nLiver ultrasound + duplex: May show a small liver or hepatomegaly, splenomegaly, \nfocal liver lesion(s), hepatic vein thrombus, reversed \ufb02 ow in the portal vein, or as-\ncites. MRI: \ue000Caudate lobe size, smaller islands of regenerating nodules, and the pres-\nence of the right posterior hepatic notch are more frequent in alcoholic cirrhosis \nthan in virus-induced cirrhosis. Ascitic tap: Should be performed and \ufb02 uid sent for \nurgent MC&S\u2014neutrophils >250/mm\n3 indicates spontaneous bacterial peritonitis (see \nlater in topic for treatment). Liver biopsy: (See p248.) Con\ufb01 rms the clinical diagnosis.\nManagement General: Good nutrition is vital. Alcohol abstinence (p280). Avoid \nNSAIDS, sedatives, and opiates. Colestyramine helps pruritus (4g/12h PO, 1h after \nother drugs). Consider ultrasound \u00b1 \ue025-fetoprotein every 6 months to screen for \nHCC (p286) in those where this information will change management. Speci\ufb01 c: For \nhepatitis-induced cirrhosis see p278. High-dose ursodeoxycholic acid in PBC (p282) \nmay improve LFT and improve transplant-free survival. Penicillamine for Wilson\u2019s \ndisease (p285). Ascites: Fluid restriction (<1.5L/d), low-salt diet (40\u2013100mmol/d). \nGive spironolactone 100mg/24h PO; \ue000dose as tolerated (max 400mg/24h)\u2014it coun-\nters deranged renin\u2013angiotensin\u2013aldosterone (RAA) axis. Chart daily weight and aim \nfor weight loss of \u2264\u00bdkg/d. If response is poor, add furosemide \u2264120mg/24h PO; do \nU&E (watch Na\n+) often. Therapeutic paracentesis with concomitant albumin infusion \n(6\u20138g/L \ufb02 uid removed) may be required. Spontaneous bacterial peritonitis (SBP): \n\ue007Must be considered in any patient with ascites who deteriorates suddenly (may \nbe asymptomatic). Common organisms are E. coli, Klebsiella, and streptococci. \ue014: eg \npiperacillin with tazobactam 4.5g/8h for 5d or until sensitivities known. Give prophy-\nlaxis for high-risk patients (\ue001albumin, \ue000PT/INR, low ascitic albumin) or those who have \nhad a previous episode: eg cipro\ufb02 oxacin 500mg PO daily. Encephalopathy: Recurrent \nepisodes may be reduced in frequency with prophylactic lactulose and rifaximin \n(p274). Renal failure: \ue001hepatic clearance of immune complexes leads to trapping in \nkidneys (\ue018 IgA nephropathy \u00b1 hepatic glomerulosclerosis). See also p275 for hepato-\nrenal syndrome.\nPrognosis Overall 5yr survival is ~50%. Poor prognostic indicators: encephalopa-\nthy; serum Na\n+ <110mmol/L; serum albumin <25g/L; \ue000INR.\nLiver transplantation is the only de\ufb01 nitive treatment for cirrhosis (p277). Acute \nindications: Acute liver failure meeting King\u2019s College criteria (see BOX \u2018King\u2019s Col-\nlege Hospital criteria in acute liver failure\u2019 p275) Chronic indications: Advanced cir-\nrhosis of any cause; hepatocellular cancer (1 nodule <5cm or \u22645 nodules <3cm).", "text_length": 4445, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 284/905)", "type": "chunk", "chunk_index": 283, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:52.536312", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:52.537075", "status": "complete", "chunks_added": 3}